Our Mission
SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (augumented intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Early detection at point of care
Nevisense
The Nevisense platform uses advanced technology powered by AI (augumented intelligence) to empower healthcare professionals by facilitating improved diagnostic accuracy, enabled disease monitoring, and early detection of melanoma at the most curable stage. Its a non-invasive measurement that provides phycisians with objective and actionable data at point-of-care.
News
Events
- 17-19 OctDermAlpinSalzburg
- 15-17 SepIFSCC Cannes 2025Cannes, France
- 10-13 SepADO JahrestagungEssen
- 3-5 SepSGDV JahreskongressSt. Gallen, CH
- 13-16 JunEACCI Congress 2025Glasgow, Scotland
- 4-5 JunNYSCC Suppliers' DayJacob Javits Convention Center in New York City
- 29-31 MayOEADF ViennaVienna, Austria
- 22-24 MayDDL FrankfurtFrankfurt, Gremany
- 14-15 MayCosmetotest 2025Lyon, France
- 30-3 AprDDG-JahrestagungBerlin, Germany
Coming events
- 4-5 AprCorius Internal CongressFrankfurt, Gremany
- 21-23 MarDERM in FrankenthalCongressForum in Frankenthal, Germany
- 7-11 Mar2025 AAD Annual Meeting - American Academy of DermatologyFlorida, Orlando
- 23-25 FebZertifizierungskurs med. TumortherapieBerlin Germany
- 14-16 FebDiad - DialThe Ritz-Carlton DIFC, Dubai, United Arab Emirates
- 15-17 NovThe 9th International Congress of Medical Excellence in Dermatology & Aesthetic MedicineDubai World Trade Center
- 24-27 Oct2024 Fall Clinical Dermatology ConferenceWynn Las Vegas, NV
- 18-20 OctDERM Alpin SalzburgSalzburg Austria
- 11-13 OctTegernseekonferenz - Bad Wiessee, DeutschlandBad Wiessee, Deutschland
- 18-20 SepSSDV Annual Congress BaselBasel Switzerland
- 10-12 JulFOBI 2024ICM Internationales Congress Center München
- 28-29 JunWSVD Graz
- 31-3 MayEACCI Congress 2024Valencia, Spain
- 29-30 MayCosmetotest 2024Lyon, France
- 9-11 MayOEADF Vienna Annual CongressVIENNA AUSTRIA
- Load more events...
Recent events
Our unique platform
Nevisense
The unique Nevisense platform utilizes advanced EIS- technology combined with AI to empower healthcare professionals by improving diagnostic accuracy, enabling disease monitoring, and facilitating early detection of skin cancer. The Nevisense procedure is non-invasive and provides clinicians with objective and actionable data, at point-of-care. It has been developed based on 20+ years of research from the Karolinska Institute and several years of clinical experience.
Lorem ipsum dolor
Lorem ipsum dolor
Integer venenatis sem in orci volutpat, eget placerat est mattis. Vivamus rhoncus leo sed nulla aliquam, id suscipit libero sagittis. Aenean vitae condimentum nisi, ac hendrerit libero.